Page last updated: 2024-11-02

4-phenylbutyric acid and Leber Congenital Amaurosis

4-phenylbutyric acid has been researched along with Leber Congenital Amaurosis in 1 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Leber Congenital Amaurosis: A rare degenerative inherited eye disease that appears at birth or in the first few months of life that results in a loss of vision. Not to be confused with LEBER HEREDITARY OPTIC NEUROPATHY, the disease is thought to be caused by abnormal development of PHOTORECEPTOR CELLS in the RETINA, or by the extremely premature degeneration of retinal cells.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, S1
Samardzija, M1
Yang, Z1
Grimm, C1
Jin, M1

Other Studies

1 other study available for 4-phenylbutyric acid and Leber Congenital Amaurosis

ArticleYear
Pharmacological Amelioration of Cone Survival and Vision in a Mouse Model for Leber Congenital Amaurosis.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 05-25, Volume: 36, Issue:21

    Topics: Animals; Blindness; Cell Survival; cis-trans-Isomerases; Dose-Response Relationship, Drug; Female; L

2016